| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26 | 27 | 29 | 76 | | Cost of Revenue | 1,500 |
-
|
-
|
-
| | | Gross Profit | (1,474) | 27 | 29 | 76 | | | Operating Expenses | | Research Development | 503 | 2,789 | 1,545 | 1,365 | | Selling General and Administrative | 431 | 2,663 | 388 | 310 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,408) | (5,425) | (1,904) | (1,599) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,382) | (5,425) | (1,903) | (1,600) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,382) | (5,425) | (1,903) | (1,600) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,382) | (5,425) | (1,904) | (1,599) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,408) | (5,425) | (1,904) | (1,599) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,408) | ($5,425) | ($1,904) | ($1,599) |
|
0.83% Nasdaq 0.00%
Income Statement
